Arteris subsidiary invests in Transchip via technology license and cash; post-money valuation ~$35.6M

Arteris, Inc.

AHK will contribute RMB 77.33M via technology license and RMB 1.7M cash, plus transfer of initial capital, for 40.321% of Transchip.
Third-party investors (SME, Luojia, Guinie) contribute RMB 76.5M (~$12M) cash for combined 38.931%.
Management Co subscribes RMB 40.77M (20.748%) for employee option plan; total capital rises to RMB 196.5M.
Technology license from AHK to Transchip covers FlexNoC, FlexWay, CodaCache, Ncore, and Resilience/AI for 5-year design term.
AHK gets one of three board seats; proceeds to fund product development using licensed technologies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.